ORGANOVO HOLDINGS, INC., a Delaware Corporation Plaintiff, v. Georgi DIMITROV, Defendant.
C.A. No. 10536-VCL
Court of Chancery of Delaware.
Date Submitted: March 3, 2017 Date Decided: June 5, 2017
LASTER, Vice Chancellor.
David L. Finger, FINGER & SLALINA, LLC, Counsel for Georgi Dimitrov.
OPINION
LASTER, Vice Chancellor.
Defendant Georgi Dimitrov moved to vacate the entry of default judgment against him. His motion is granted.
I. FACTUAL BACKGROUND
The facts are drawn from the Verified Complaint (the “Complaint“) and the materials submitted by the parties during post-default proceedings. A default judgment “deem[s] admitted all the well-pleaded
A. The Parties
Plaintiff Organovo Holdings, Inc. (“Organovo” or the “Company“) is a Delaware corporation with its headquarters in San Diego, California. The Company designs and creates functional human tissues through its use of proprietary three-dimensional bioprinting technology. In July 2013, the Company listed its common stock on the New York Stock Exchange. In the months following its initial listing, the Company‘s stock price fluctuated widely. Between October 2013 and March 2014, the Company‘s stock price ranged between $5.55 per share and $12.75 per share, with an average trading price of $8.78.
Dimitrov is a man of mystery. In February 2014, he formed non-party Simeon Research, LLC (“Simeon“), a Delaware limited liability company. Shortly afterwards, he created a website for Simeon at the URL www.simeonresearch.com. He also secured for Simeon the Twitter handle @SimeonResearch. Simeon‘s Twitter bio described its feed as “long/short analytical equity research.”2
Simeon engaged in a single activity: publishing negative information about the Company. In March and April 2014, Dimitrov published two reports in Simeon‘s name. Dimitrov called attention to these reports by posting sixty-five comments on Simeon‘s Twitter account.
B. The March Report
In March 2014, Dimitrov posted a fifty-seven page report on Simeon‘s website titled “Organovo: Dissecting the Fairy Tale—Full Report” (the “March Report“).3 Dimitrov styled the March Report to look like work product from a professional equity research firm. He created official-looking letterhead and included a standard anti-reliance disclaimer. The report claimed to be the product of “hundreds of hours of intensive research from hundreds of journal publications, never-before seen primary sources, and extensive industry interviews.”4 It contained 189 footnotes citing public filings, news articles, and academic papers. It included numerous pictures and charts. Less professionally, it made extensive use of bold and underlined typeface, which this decision omits.
The beginning of the March Report summarized its key points.
- “Organovo‘s bioprinting technology is not pivotal to tissue engineering or organ fabrication. Simeon Research publishes for the first time to the public the views expressed by Organovo‘s scientific founder: bioprinting—‘it‘s nothing, it‘s a stupid exercise.‘”
- “Organovo has misled investors in multiple instances about its technology, its competitive position, and what it can deliver.”
- “A number of companies and academics have developed bioprinters that have better capabilities than those of Organovo‘s NovoGen bioprinter.”
- “Organovo has failed to deliver on its promises a number of times in the past, and has experienced a wash-out of material partnerships.”
“Organovo‘s liver tissue data is years behind competitors in the 3D liver toxicology market.” - “Organovo‘s intellectual capital has deteriorated significantly, as the founder exited and key scientistis left.”
- “The scientific consensus on organ printing is that the media has hyperbolized it far and above reality while the public has bought in....”
- “Organovo has experienced a rabid run-up in price that is incongruent with its real valuation, which we believe to be $1.35/share.”5
The bulk of the March Report focused on the bioprinting industry‘s lack of commercial promise and the Company‘s technical inferiority to competitors in that field. It mixed in accusations that the Company‘s management had misled investors and engaged in self-dealing.
Only the last three pages of the March Report analyzed the value of the Company‘s stock. Much of this final section consisted of quotes from outside analysts. The only original valuation work appeared in the final two pages. Simeon ultimately valued Organovo based on an asset-based approach described in a single paragraph:
We have demonstrated that Organovo lacks a competitive moat—its bioprinting technology is just a “stupid exercise” in the words of its scientific founder and it has been eclipsed by other bioprinting manufacturers while its liver tissue is inferior to the product offerings of other companies. Given this, we think it would be fairly easy to replicate every tangible asset on which Organovo‘s valuation is based—it thus makes a good basis for valuing the company. Bioprinters from a competing company. A warehouse. 35 scientists. $50M in cash. We will grant the exceedingly generous 5x multiple to Organovo‘s $13.5M in R & D spent since inception. All of this brings us to ≈ $120M. At the current diluted share count, Organovo would be valued at $1.35/share. We think this is a fair value and even generous given the cascade of red flags about the company and its management.6
The Company responded to the March Report on its website. Among other things, the Company asserted that the report “was issued by or at the request of a short seller or short-sellers.”7
C. The April Report
The March Report portended further publications. “This report encompasses roughly a third of the information Simeon Research has uncovered. Additional reports will follow in the coming weeks.”8 In April 2014, Simeon published a second report on its website titled “Bargaining with the Devil: How Organovo Used Fraudulent Brokers and Promoters to Sell its Shares and Story” (the “April Report“).9 Dimitrov prepared the April Report in the same style as the March Report.
The April Report asserted that the Company was defrauding its investors. The first sentence of the April Report stated, “Organovo has carried out one of the most successful penny stock promotions currently listed on a major exchange.”10 The April Report summarized its support for this assertion as follows:
“Organovo paid millions to brokers with fraudulent histories to promote shares to individual investors.” - “Organovo paid for stock promotion services without disclosing the payments—it enlisted ProActive Capital, which has been accused of paying a cadre of authors to write promotional articles covering client stocks without SEC-required disclosures.”
- “During the course of this stock promotion, we believe that pro-Organovo articles may have been published in exchange for compensation without any disclosure.”
- “Organovo has spent nearly 3x as much on selling shares and promoting its stock as it has on Research & Development since the company was founded.”11
The April Report claimed that Simeon had “submitted [its] findings to the SEC and look forward to their response.”12 It touted that Organovo‘s stock price had fallen 9.3% since the publication of the March Report.
The April Report responded to the Company‘s claim that Simeon was working on behalf of short-sellers. It stated: “We want to make unequivocally clear that our research and publications are in no way whatsoever the result of a ‘request’ or compensation by any third party. Our reports represent Simeon Research‘s original investigations and analysis. . . . [W]e stand by our work and believe in its accuracy.”13 The April Report also claimed that “Organovo has, in the past, attempted to smear critical research of its valuation by calling negative views ‘short and distort’ tactics.”14
D. The Tweets
Dimitrov called attention to Simeon‘s two reports through the Company‘s Twitter account. After releasing the reports, Simeon sent out at least sixty-five tweets, all of which concerned the Company. For example, two tweets on April 8, 2014 stated, “Simeon Research reiterates $1.35 price target for Organovo shares . . . .” and “[Organovo] is down 4% today and 12% since our first report in March. We believe downside exists to $1.35/share.”15
E. The Simeon Action
On April 21, 2014, the Company filed a lawsuit against Simeon in this court (the “Simeon Action“).16 Because the Company did not yet know who controlled Simeon, the Company included “unnamed Does 1-25” as defendants.
The complaint alleged that the March and April Reports (together, the “Simeon Reports“) contained numerous false or misleading statements.17 The Company specifically cited the following:
- “[Organovo] has failed to achieve renewal from its 2 key pharmaceutical partners and secured fluff PR pieces instead.”
- “No researcher will shell out $200,000 to buy Organovo‘s bioprinter when they can make a comparable or better bioprinter on their own for a fraction of the price. Organovo has placed 6 of these bioprinters
with academic centers since 2009, or, 1 bioprinter per year. And they didn‘t receive a cent—they loaned the printers at no cost.” - “Leapfrogging Organovo, researchers at Scotland‘s Herriot-Watt University have made a revolutionary breakthrough in tandem with privately-held Roslin Cellab by bioprinting human embryonic stem cells with high levels of viability (>95% with identical physiology post-printing) using a modified MakerBot printer. The work, unlike the claims of Organovo, has been published in the journal Biofabrication—it has been called ‘the greatest breakthrough in 3D bioprinting to date.‘”
- “Keith Murphy [the Company‘s CEO] tells investors that Organovo can leverage its platform to achieve partnership deals that bring in $10,000,000-$30,000,000 per deal plus a 3%-7% royalty. That is 7 times to 22 times greater than Organovo‘s largest deal-to-date, a deal that has not been renewed.”
- “The company publicizes any thread of good news while sweeping dеtrimental events under the rug without mention.”
- “Of course, Organovo knows [that it did not develop the first bioprinter], because it worked with nScrpyt to develop its own bioprinter.”
- “[E]ither Organovo‘s management made dubious claims to raise money from investors, or its employees and technology failed to achieve their targets.”
- “Organovo has a history of serial dilution and insider sales in the last half-year exceed the amount of money the company invested in Research & Development.”
- “Back in 2012, every private investor in Organovo sold their shares into the market, liquidating 32.1M shares (99.7% of their holdings) at a blended price of $3.02/share.”18
- “[The fact that] Organovo has spent triple its entire R & D budget since inception on raising money from small-time investors and stock promotion demonstrates that Organovo is more penny-stock promotion than legitimate company.”
- “Organovo has spent nearly three times as much money ($36.5 million) compensating its brokers and discounting shares in a follow-on as it has on Research and Development ($13.5 million) since the Company‘s inception.”
- “ProActive provided Organovo a number of stock promotion services in exchange for Organovo‘s business—many had none of the legally-required disclosures.”
- “ProActive Capital and DreamTeamGroup have absolutely no disclosures on any of their operated websites that they were compensated by Organovo for their promotions.”
- “Organovo paid these brokers more than $1 in cash, stock, and warrants for every $1 raised from investors.”19
The Company brought claims for libel, libel per se, and tortious interference with prospective economic advantage. The Company sought an order “(i) enjoining Defendant from making or publishing any further false and defamatory statements regarding Plaintiff, and (ii) compelling Defendant to remove any and all defamatory
After suing Simeon, the Company identified Dimitrov by subpoenaing Simeon‘s registered agent. On May 15, 2014, the Company served Dimitrov with a subpoena at his apartment in Alexandria, Virginia.21
F. Simeon Defaults.
Dimitrov caused Simeon to retain counsel, and Simeon moved to dismiss the Simeon Complaint for lack of subject matter jurisdiction, lack of personal jurisdiction, and failure to state a claim upon which relief could be granted.22 Then, on June 10, 2014, Simeon‘s counsel moved to withdraw, stating that his client “has ceased communicating with counsel.”23 On June 16, I issued an order to show cause directing Simeon to file any opposition to the motion to withdraw by a specified date. The order warned Simeon that “[i]f no action is taken by this date, the Motion to Withdraw will be granted.”24 Simeon did not respond. On July 17, I granted the motion to withdraw.25
From that point on, Simeon did not participate in the litigation. The Company asked the court to deny Simeon‘s motion to dismiss and enter a default judgment. I agreed in part and denied the motion to dismiss. I declined to enter a default judgment and instead provided Simeon twenty-one days to answer the complaint. Simeon again did not respond.
On August 26, 2014, the Company renewed its motion for default judgment. By order dated September 3, 2014, I entered a default judgment against Simeon in the form requested by the Company. The final order permanently enjoined Simeon from “making any further defamatory statements about [the Company]” or “publishing or posting any libelous statements about Plaintiff anywhere on the Internet.” Simeon was also ordered to “immediately remove or cause to be removed any and all libelous statements from its website, Twitter account, or any other public websites,” including the Simeon Reports and all posts on Simeon‘s Twitter account.26
G. This Action
On January 13, 2015, the Company filed this action against Dimitrov. The Company contended that Dimitrov acted through Simeon and used the entity “solely for the purpose of allowing him to shield his identity and assets, and to create the appearance that a legitimate research company was challenging the business of [the Company].”27 The factual allegations of the Complaint were substantially identical to those alleged in the Simeon Complaint.
The Company asserted for claims libel, libel per se, tortious interference with prospective economic advantage, and negligence. The Complaint sought an injunction substantially identical to the one asked for and obtained by default in the Simeon Action:
[T]he court should enter a permanent injunction (i) compelling Dimitrov to remove any and all defamatory and violative statements from any website he maintains and the @SimeonResearch Twitter account (ii) enjoining Dimitrov
from forming or creating new entities with the purpose of preparing and/or publishing any false and defamatory statements regarding [the Company.], and (iii) enjoining Defendant from forming or creating new entities with the purpose of preparing and/or publishing any false and defamatory statements regarding [the Company.]28
Despite seeking this relief, the Company acknowledged in its Complaint that Simeon‘s website had been taken down and that all of Simeon‘s tweets about the Company had been removed.29
H. Dimitrov Defaults.
The Company attempted to serve Dimitrov at his last known address in Alexandria, Virginia. Someone accepted delivery, then returned the documents to UPS, suggesting that Dimitrov either no longer resided there or was evading service. The Company next attempted to contact Dimitrov via his last-known phone number, but he did not answer and his voicemail was full. The Company also e-mailed Dimitrov at his last known e-mail address, but Dimitrov did not respond. The Company then searched public records and sent a process server to an address in New York City, but a building representative told the process server that Dimitrov did not reside there.30
The Company next sought and received permission to effectuate service by publication. The order authorizing service by publication directed Dimitrov to appear on May 18, 2015. It warned that “failure to appear shall be cause for entry of judgment by default.”31 The Company published the required notice on March 20, March 27, and April 3, 2015.
On May 13, 2015, over a month after the last notice by publication, Dimitrov e-mailed the Company‘s counsel from a new e-mail address. His email stated:
Hello,
My name is Georgi Dimitrov. I recently discovered through a posting on Delaware Online that Organovo has filed a civil suit against me due to my publications through my LLC, Simeon Research. I am writing first to ask the purpose of the suit, given my impression that by conceding the suit against Simeon Research and removing all research material and statements regarding Organovo the matter would be concluded.
Second, I am writing to inform you that I am currently in Europe, and due to personal matters am wholly unable to be present in court on May 18th. Therefore, I hope that a mutually favorable resolution can be reached, and in the meanwhile, I hope that you would see fit to at least delay the court date.32
Dimitrov did not contact the court.
By letter dated May 15, 2015, Organovo submitted Dimitrov‘s letter to the court and asked to proceed with the hearing as scheduled. The Company explained the lengths to which it had gone to serve Dimitrov and provide notice of the hearing. The Company also discussed the timing of Dimitrov‘s email:
In his May 13 e-mail, Mr. Dimitrov claims to have “recently discovered through a posting on Delaware Online that Organovo has filed a civil suit against me due to my publications through my LLC, Simeon Research.” On
this point, we note that Organovo arranged for the Order to be published in The News Journal on March 20, March 27, and April 3, 2015. Thus, Mr. Dimitrov‘s e-mail came more than 40 days after the most recent date the Order was published in The News Journal.33
The Company inferred that Dimitrov “has gone through great effort to avoid learning the ‘purpose’ of this lawsuit.”34 The Company cited precedents in which Delaware courts had scheduled hearings and entered default judgments when parties failed to attend.35
The Company provided a copy of its letter to Dimitrov using the email address that he had used to contact the Company. From that point forward, copies of all filings in this case were sent to Dimitrov at that email address. Dimitrov did not respond to the Company‘s letter.
The hearing went forward as scheduled on May 18, 2015. Dimitrov did not appear. I held that he had defaulted.
I. Post-Default Proceedings
Despite ruling that Dimitrov was in default, I did not enter the form of default judgment that the Company had proposed. I instead instructed the Company‘s counsel to brief two matters: (i) the amount of damages, and (ii) whether the requested injunctive relief constituted an unconstitutional prior restraint on future speech.
By letter dated September 16, 2015, the Company submitted a Proposed Order and Final Judgment of Default (the “Proposed Final Order“). The Proposed Final Order included a request that Dimitrov disgorge his trading profits. This was the first time that the Company had requested this relief. Lacking any public records reflecting Dimitrov‘s trades, the Company sought an order compelling Dimitrov to provide them. Dimitrov did not oppose the request, and I granted it.
The Company commendably provided thorough and evenhanded briefing on the constitutional issues raised by its request for injunctive relief. The Company proposed a narrowly tailored injunction that permanently enjoined Dimitrov from republishing the content of the Simeon Reports and tweets. The Company agreed that in any future proceeding to enforce the injunction, the Company would bear the burden of establishing Dimitrov‘s non-compliance, which Dimitrov could rebut by demonstrating that the defamatory statements had since become true or were not defamatory.
The Company was less modest in its damages request. The Company claimed general damages equal to the decline in the Company‘s market capitalization during the twenty-six day period when Dimitrov published the Simeon Reports and tweets. During that period, the Company‘s stock traded at an average price of $7.79 per share, compared to $9.67 in the thirty days preceding his publications. The Company‘s damages theory implied that Dimitrov was solely responsible for the aggregate decline in the Company‘s stock price.
The Company‘s damages theory yielded general damages of $174,311,980.83. That eye-popping figure would rank among the largest recoveries that this court has awarded. In the alternative, the Company proposed using an index to factor out general market and industry conditions. This marginally more conservative approach
The Company did not stop at general damages. It also requested a large amount of special damages. The Company claimed harm from its “impaired ability to raise capital” after Dimitrov‘s publications. When Dimitrov published the Simeon Reports and tweets, the Company was in discussions with an investment bank about raising $60 million in financing. The Company claimed, without elaboration, that Dimitrov‘s actions “caused Organovo to put the brakes on the planned financing.”37 Instead, the Company raised $16.6 million by selling shares in below-market offerings of common stock. The offerings reduced the number of shares availаble for issuance under the Company‘s shelf registration statement, which forced the Company to file another shelf registration. The Company later closed on an underwritten public offering that raised gross proceeds of $46.1 million. The Company claimed that Dimitrov should be held responsible for $13.9 million, representing the difference between the $60 million in financing that the Company had discussed a year earlier and the $46.1 million that the Company raised in its underwritten offering.
The Company also identified $70,000 in public relations costs incurred responding to Dimitrov‘s publications. The Company‘s total request for special damages equaled $13,970,000.
During a hearing on February 4, 2016, I choked on the Company‘s aggregate damages request and asked the Company to reconsider the magnitude of the damages it was seeking. On May 2, the Company submitted a revised damages request. The Company reduced its request for general damages to $38,442,781. The Company also limited its request for special damages to the $70,000 in public relations costs. The Company again requested disgorgement of Dimitrov‘s trading profits, which it calculated as amounting to $33,235.65. The Company continued to request a permanent injunction against the republication of the Simeon Reports and tweets.
J. Dimitrov Enters a Limited Appearance.
On June 27, 2016, before this court had entered a final order, Dimitrov retained the counsel that originally represеnted Simeon in the Simeon Action. Through counsel, he entered a limited appearance and moved to vacate the default judgment. He argued that the judgment was void because the court lacked subject matter jurisdiction over the dispute and could not exercise personal jurisdiction over him. On March 3, 2017, the court heard oral argument.
II. LEGAL ANALYSIS
The entry of a default judgment does not prevent the defaulting party from appearing and contesting the default. “A defendant is always free to ignore the judicial proceedings, risk a default judgment, and then challenge that judgment on jurisdictional grounds. . . .”38 That is what Dimitrov has done here.
The Court of Chancery can exercise subject matter jurisdiction only when a case falls into one of three buckets.40 First, jurisdiction exists if a plaintiff states an equitable claim.41 Second, jurisdiction exists if a plaintiff requests equitable relief and there is no adequate remedy at law.42 Third, jurisdiction exists by statute.43 Additionally, the clean-up doctrine provides thаt if this court would have equitable jurisdiction over a part of a controversy, then it can address the remaining portions of the controversy as well.44
“Equitable jurisdiction must be determined from the face of the complaint at the time of filing, with all material factual allegations viewed as true.”45 “In deciding whether or not equitable jurisdiction exists, the Court must . . . focus upon the allegations of the complaint in light of what the plaintiff really seeks to gain by bringing his or her claim.”46 “Chancery jurisdiction is not conferred by the incantation of magic words. . . . If a realistic evaluation leads to the conclusion that an adequate remedy is available, this court . . . will not accept jurisdiction over the matter.”47
The Complaint asserts common law claims for libel, tortious interference with prospective economic advantage, and negligence. None of these are equitable claims, and the complaint does not invoke a statute that confers subject matter jurisdiction on the court. Consequently, this court only has subject matter jurisdiction over the case if the Complaint sought a viable equitable remedy.
The Company has cited two equitable remedies. The first is a permanent injunction against future defamation. The second is an order compelling Dimitrov to disgorge his profits. On the facts of this case, neither provided a basis for subject matter jurisdiсtion. The default is therefore vacated.
A. Injunctive Relief
The Complaint alleged that Dimitrov defamed the Company and sought a permanent injunction barring Dimitrov from engaging in future acts of defamation. Whether that request for relief supported the exercise of equitable jurisdiction necessitates a review of three strands of authority: (i) the general limitation on the availability of an injunction when an adequate remedy exists at law, (ii) the specific limitation on the ability of a court sitting in equity to enjoin defamatory speech, and (iii) the narrow exceptions to the general rule against injunctions in defamation cases. On the facts presented, the Company‘s request for a permanent injunction against future defamation did not provide a sufficient basis for exercising equitable jurisdiction.
1. An Adequate Remedy At Law
Generally, “a party injured as a result of a tort has a complete and adequate remedy at law in the form of an action for damages[.]”48 Defamation is a common law tort.49 This court lacks juris-
In this case, a realistic evaluation of the Complaint demonstrates that the Company had an adequate remedy at law in the form of money damages. The Complaint alleged that Dimitrov‘s defamatory statements negatively affected the Company‘s stock рrice. The Company asked for an award of damages equal to the aggregate value of the decline in its market capitalization. Setting aside whether that was an appropriate quantum of relief, it demonstrated that the Company‘s injury could be remedied through a monetary award.
The Company‘s request for injunctive relief was forward-looking. Although the Company‘s past harm could be remedied with money, the Complaint sought an injunction against further acts of defamation. An injunction against future wrongdoing is not generally available.52
The Complaint did not meet this test. After the Simeon Action, Dimitrov stopped defaming the Company. He complied with this court‘s order by removing the Simeon Reports and the Simeon Tweets and not publishing any additional defamatory material.54 When the Company filed suit, there was no “reason to believe that [Dimitrov would] continue his wrongful course of conduct.”55
Judged under traditional equitable standards, therefore, the Complaint‘s request for an injunction did not provide a basis for subject matter jurisdiction. That conclusion becomes all the more clear when evaluated under the special rules that apply to requests for injunctions against future defamatory statements.
2. The No-Injunction Rule
The ability of a court tо issue injunctive relief is even more constrained in a defamation case than in a garden-variety tort case or breach of contract case. Traditionally, the reason for the special rule was jurisdictional. Today, the rule is primarily remedial but also rests on the importance afforded to the constitutional protections of speech.
Historically, equity declined to exercise jurisdiction over a claim for defamation based on a prayer for injunctive relief. This broadly held view was crystallized in the “traditional maxim that ‘equity will not enjoin a libel.‘”56 A more historically accurate formulation was that “equity has no jurisdiction to enjoin a libel.”57
The no-injunction rule originated in England during the eighteenth century, when one of Parliament‘s major victories in the battles for freedom of the press was
The merger of the historically separate courts of law and equity undercut the traditional allocation of jurisdiction over defamation to the law courts, first in England and then in the United States. After England unified its separate court systems in 1873, English courts began to issue permanent injunctions in defamation cases after a jury had found the defendant liable, but “the judge could enjoin no more than what the jury had found to be defamatory.”62
Although this step was initially controversial, by the end of the nineteenth century English courts also were willing to issue preliminary injunctions pending the jury‘s decision.63
During the late nineteenth and early twentieth centuries, many American jurisdictions also merged their separate systems of law and equity.64 American courts, however, maintained the no-injunction rule in the face of contrary British practice.65 The leading decision grounded the continuing adherence to the no-injunction rule on traditional equitable principles:
Charges of slander are peculiarly adapted to and require trial by jury; and exercising, as we do, authority under a system of government and law which by a fundamental article secures the right of trial by jury in all cases, at common law, and which by express statute declares that suits in equity shall not be sustained in any case where a plain, adequate, and complete remedy may be had at law, as has always heretofore been considered the case in causes of libel and slander[,] we do not think that we would be justified in extending the remedy of injunction to such сases.66
In the federal courts and the majority of states that unified their systems, courts recast the earlier rule about equity lacking jurisdiction over a defamation claim as a principle that equity would not grant injunctive relief to restrain a libel.67 In the
The protection for freedom of speech in the federal and state constitutions provided additional justifications for American resistance to the issuance of injunctions in defamation cases.69 In 1931, the United
Although the underlying rationale has evolved over time, the general rule continues to be that a court of equity will not issue an injunction against future defamatory speech. In courts where law and equity are separate, the rule is jurisdictional. In cоurts where law and equity have merged, the rule is prudential. Under both systems, the rule accords with constitutional doctrine. The upshot is the same: a court of equity generally cannot issue an injunction in a defamation case.73
Judged under the general test for determining whether an adequate remedy exists at law, the Complaint‘s request for an injunction did not support equitable jurisdiction. Judged under the special rules that apply to requests for injunctions in defamation cases, that result is all the more clear.
3. Two Recent Exceptions to the Anti-Injunction Rule
Despite the broad rule against injunctive relief in defamation cases, courts in the
a. Trade Libel
During the twentieth century, American courts increasingly granted preliminary injunctions to address “trade libel,” a concept that initially covered statements “disparaging the quality of property,” then expanded “to encompass any injury to economic advantage arising from false derogatory statements.”74 Courts divided on the
A decision from this court examined the propriety of an injunction for trade libel
- “The famous ‘Pitco Frialators’ are manufactured exclusively by the J.C. Pitman & Sons, Inc. . . . Any association of the name Pitman with other than the ‘Pitco Frialators’ is an attempt to confuse the trade and introduce a copy of our ‘Pitco Frialator’ . . . .”82
- “[Pitman Manufacturing] has started a campaign to confuse and deceive the trade; by unlawfully using the name Pitman; by unlawfully attempting to copy the genuine Pitman Fryer; by unlawfully producing the advertising matter of J.C. Pitman and Sons, Inc.; and by unlawfully attempting to force their inferior product on the trade in place of the genuine Pitco Frialator.”83
- “It has become necessary to resort to court proceedings to stop this obvious deception; to stop the unlawful sale of this New Fryer; and to stop this new concern from capitalizing unlawfully on the good will honestly built up by J.C. Pitman and Sons . . . .”84
- “Any legitimate concern like yourself that buys or sells the products of this outfit might unwittingly become involved in this litigation—which would
be very costly to you, and very regrettable to J.C. Pitman and Sons.”85 - “We, therefore, advise you not to deal with this new corporation until its rights to manufacture and your right to buy or sell this questionable product is decided upon by the courts.”86
Pitman Manufacturing brought a counterclaim alleging that the statements were defamatory and sought a preliminary injunction prohibiting further publication of the letters.
In ruling on the application for a preliminary injunction, the decision first summarized the existing authorities:
Prior to the Judicature Act of 1873, the English Court of Chancery would not enjoin the publication of a mere trade libel . . . But while the right to enjoin a trade libel is now established in that country, it will only be exercised in plain cases of irreparable injury. It is unnecessary to consider the peculiar statutory provisions involved, and whether there was any real enlargement of the inherent powers of equity.
When no breach of trust or of contract rights appears, the American courts have almost uniformly followed the English rule prior to 1873, and have refused to enjoin mere trade libels. When, however, a court of equity has jurisdiction on some other ground, the American courts will also usually enjoin the continued publication of a trade libel incident thereto. That is true when the libel is accompanied by some act of un-
fair business competition, if irreparable damage is imminent . . . .87
Distilling a rule, the decision stated: “The necessary conclusion therefore is that a continued course of wrongful action may, ordinarily, be stopped by injunction, although it includes a trade libel.”88 The court held that “[i]ntimidating possible customers by baseless threats to sue, should they deal with the complainant, comes within that rule.”89 The court therefore issued an injunction enjoining Pitman & Sons from sending out more letters. This instrumentalist approach to injunctive relief accorded with the middle approach that many other jurisdictions had endorsed.
Viewing the Complaint charitably, the Company might be seen as having attempted to plead a trade libel. Count III of the Complaint asserted a claim for tortious interference with prospective economic advantage. Unlike defamation, injunctive relief is a common and non-controversial remedy for tortious interference with prospective economic advantage.90
Courts have recognized that a request for equitable remedies for tortious interference with prospective economic advantage can provide the requisite basis for equitable jurisdiction that can justify a related injunction against future speech.91
In this case, however, the Complaint‘s allegations failed to state a claim for tortious interference with prospective economic advantage.92 To state such a claim, a plaintiff must plead “(a) the reasonable probability of a business opportunity, (b) the intentional interference by the defendant with that opportunity, (c) proximate causation, and (d) damages . . . .”93 “[T]o plead a reasonable probability of a business opportunity, [a plaintiff] must identify a specific party who was prepared to entered into a business relationship but was dissuaded from doing so by the defendant and cannot rely on generalized allegations of harm.”94 While the plaintiff does not need to identify a party by name, the plaintiff must do more than offer “vague statements about unknown customers.”95 A plaintiff cannot plead this
Here, the Complaint alleged only that Dimitrov interfered with “valuable prospective economic relationships and business opportunities with its bankers, customers, lenders, investors and prospective investors . . . .”97 The Complaint provided no factual support for this conclusory allegation. The Complaint stated that the Company “believes it has lost potential investors,” but provided no details.98 The Complaint never specified any customer relationships that Dimitrov harmed. Vague allegations of this sort are insufficient.
There is also nothing in the Complaint to support a reasonable inference that Dimitrov intended to interfere with the Company‘s business relationships. Therе was no reason to believe that Dimitrov, who was unaffiliated with the Company, had any knowledge of the Company‘s ongoing discussions with potential investors. In fact, the Complaint ascribed a different intention to Dimitrov. “Defendant‘s acts in publishing the [Simeon Reports] and the [Simeon Tweets] were intended solely to drive down the price of Plaintiff‘s common stock, so that Defendant could effectuate profitable short sales of that stock.”99
Count III thus failed to state a claim upon which relief can be granted. It therefore cannot provide a route to an injunction against defamatory statements that are part of a larger trade libel. It consequently cannot provide a basis for subject matter jurisdiction.
b. Adjudicated Falsehoods
During the twentieth century, American courts also revisited the earlier resistance to granting injunctions in traditional defamation cases. Citing the growing willingness to consider injunctions in cases of trade libel, courts and commentators argued that the parity of reasoning called for injunctive relief for defamation in general.100 Spurred by these insights, American courts began issuing permanent injunctions as part of a remedial package after speech had been judged defamatory. Five state Supreme Courts,101 three United
In my view, the potential availabil-
Unlike in a jurisdiction where law and equity have merged, there is another court that can capably adjudicate the claim. “Equity and law courts should not be placed in the position of competing for
Because Delaware has maintained its separate courts of law and equity, the potential availability of permanent injunctive relief following an adjudication of falsity did not provide grounds for filing this case in this court. This case belonged in the Superior Court.
B. Disgorgement
The other equitable remedy that the Company cites is disgorgement. As a threshold matter, the Complaint did not ask for this form of relief. “Equitable jurisdiction must be determined from the face of the complaint at the time of filing.”113 The Company therefore cannot rely on disgorgement to ground jurisdiction in this court.
Disgorgement only entered the picture eight months after the Complaint was filed. During the damages hearing, I balked at the Company‘s request for a prodigious award that seemed disproportionate to the harm it had suffered. I mentioned that disgorgement of Dimitrov‘s trading profits might be a more fitting measure. Candidly, I had not considered when making this comment whether a disgorgement remedy comported with formal doctrine. My thought instead was that it provided a good starting point for measuring proportionality.
After reviewing pertinent authority, the remedy of disgorgement appears sufficiently disconnected from the tort of defamation that that a request for disgorgement would not have supported equitable jurisdiction. “Remedies for libel and slander are traditionally damages remedies. Restitutionary remedies have not been applied to defamation cases . . . .”114 While theoretically a plaintiff might seek disgorgement or another restitutionary remedy as an alternative to damages,115 the handful of cases to consider the issue have rejected these requests.116
It still seems to me that when sizing a damages award, a court might well consider the vast difference between the magnitude of Dimitrov‘s trading profits and the size of the Company‘s damages request. From a doctrinal standpoint, however, disgorgement was not available as a remedy for defamation and does not provide a basis for this court to exercise equitable jurisdiction.
III. CONCLUSION
Neither of the equitable remedies that the Company has cited support the existence of jurisdiction in this court. There are no other grounds for equitable jurisdiction. This court therefore lacked subject matter jurisdiction over the Complaint. The motion to vacate the default judgment is granted. The case is dismissed for lack of jurisdiction, subject to the Company electing to have the matter transferred to the Superior Court.120
